Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.

PRESS RELEASEAB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A ...

Edward Hopper, loneliness epidemic, roommate marriages, politics, social media, and economics reveal why Americans are alone ...

December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med subsidiary, ...

The average life expectancy has increased dramatically in Nigeria. A male child born in 1900 could expect to live for only 46 years, whereas one born today can expect to live more than 72 years. A ...

Victims of convicted sex offender Jeffrey Epstein share a hug after learning that the Senate passed the Epstein Files ...

Pursuant to a purchase agreement between Winsome and Albemarle, Winsome is assigning its Case Lake offtake rights to Albemarle. Winsome will retain its 15.8% shareholding of Power Metals and looks ...

Rocket Lab leads with reusable Neutron fairing, expands 500–1,000kg satellites, and grows higher-margin space systems revenue ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...

The donor, who was not identified, was paid to donate as a student beginning in 2005, according to the report.